Apollon Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
10,855
+104
| +1% | +$12.6K | 0.03% | 471 |
|
|
2025
Q1 | $1.2M | Sell |
10,751
-1,094
| -9% | -$122K | 0.03% | 453 |
|
|
2024
Q4 | $1.15M | Buy |
11,845
+926
| +8% | +$90.1K | 0.03% | 466 |
|
|
2024
Q3 | $1.26M | Sell |
10,919
-494
| -4% | -$56.8K | 0.04% | 415 |
|
|
2024
Q2 | $1.22M | Sell |
11,413
-1,582
| -12% | -$168K | 0.04% | 407 |
|
|
2024
Q1 | $1.26M | Sell |
12,995
-55
| -0.4% | -$5.32K | 0.04% | 408 |
|
|
2023
Q4 | $1.32M | Buy |
13,050
+7,990
| +158% | +$807K | 0.05% | 363 |
|
|
2023
Q3 | $515K | Buy |
5,060
+273
| +6% | +$27.8K | 0.03% | 543 |
|
|
2023
Q2 | $483K | Buy |
4,787
+819
| +21% | +$82.6K | 0.02% | 599 |
|
|
2023
Q1 | $365K | Sell |
3,968
-118
| -3% | -$10.9K | 0.02% | 625 |
|
|
2022
Q4 | $371K | Sell |
4,086
-1,496
| -27% | -$136K | 0.03% | 601 |
|
|
2022
Q3 | $424K | Buy |
5,582
+1,638
| +42% | +$124K | 0.03% | 495 |
|
|
2022
Q2 | $333K | Sell |
3,944
-1,258
| -24% | -$106K | 0.03% | 539 |
|
|
2022
Q1 | $456K | Sell |
5,202
-5,127
| -50% | -$449K | 0.03% | 488 |
|
|
2021
Q4 | $904K | Buy |
10,329
+6,013
| +139% | +$526K | 0.07% | 305 |
|
|
2021
Q3 | $353K | Buy |
+4,316
| New | +$353K | 0.05% | 319 |
|
|
2020
Q3 | – | Sell |
-11
| Closed | -$1K | – | 514 |
|
|
2020
Q2 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 701 |
|